Einhorn Andrew J. 4
4 · Osmotica Pharmaceuticals plc · Filed Jan 30, 2020
Insider Transaction Report
Form 4
Einhorn Andrew J.
Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2020-01-28$7.00/sh−9,184$64,288→ 95,665 total
Holdings
- 22,852(indirect: By family limited liability company)
Ordinary Shares
Footnotes (1)
- [F1]The Reporting Person is the sole managing member of the limited liability company and, as a result, may be deemed to beneficially own the ordinary shares held by the limited liability company. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.